학술논문

Neoadjuvant sintilimab and chemotherapy in patients with potentially resectable esophageal squamous cell carcinoma (KEEP-G 03): an open-label, single-arm, phase 2 trial
Document Type
Journal
Source
JOURNAL FOR IMMUNOTHERAPY OF CANCER; FEB 2023, 11 2, pe005830 11p.
Subject
Language
English
ISSN
20511426